May 8, 2020 / 11:09 AM / 21 days ago

BRIEF-Immunic Inc Reports Q1 Loss per Share $0.79

May 8 (Reuters) - Immunic Inc:

* IMMUNIC, INC. REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND HIGHLIGHTS RECENT ACTIVITY

* Q1 LOSS PER SHARE $0.79

* PREPARING A PHASE 2 CLINICAL DEVELOPMENT PROGRAM FOR IMU-838 AS A POTENTIAL TREATMENT FOR COVID-19

* TOP-LINE DATA FROM PHASE 2 EMPHASIS TRIAL OF IMU-838 IN RRMS IS EXPECTED TO BE AVAILABLE IN Q3 OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below